Our leadership team
Thomas Senderovitz
|
Contactths@dkma.dk EducationMD from the University of Copenhagen 1992, various management and leadership courses, e.g. from the Center for Creative Leadership in the USA. Short descriptionThomas Senderovitz took over as Director General of the Danish Medicines Agency on 1 April 2016. His career includes more than 20 years working intensively with medicinal products and he has held several senior positions in international biopharmaceutical companies (Ferring Pharmaceuticals, UCB Pharma, Grünenthal GmbH). Most recently, Thomas Senderovitz was a member of the management team of the global contract research organisation PAREXEL engaging in clinical research for pharmaceutical and biotechnological companies. Thomas Senderovitz previously worked at the Clinical Pharmacological Department at Bispebjerg Hospital in Copenhagen. |
Jakob Cold
|
Contactjco@dkma.dk EducationMSc in Political Science from the University of Copenhagen and the University of Konstanz, Germany. ResponsibilitiesCross-cutting strategy, finance, IT, HR and quality etc. Short descriptionJakob Cold’s core competencies include institutional cohesion and design of processes, analyses and concepts, ensuring that business, finance, IT and HR etc. are linked strategically and communicated internally and externally. Jakob’s career includes positions at the Danish Ministry for Children, Education and Gender Equality, the Danish Ministry of Finance, the Danish Ministry of Justice, Realdania, the Danish Health Authority and the Danish Medicines Agency. |
Sara Westengaard Guldagger
|
Contactsawg@dkma.dk EducationMaster of Laws ResponsibilitiesExecutive team services, cross-functional legal and international tasks and contingency planning. Short descriptionSara Westengaard Guldagger joined as Director of Division of the new Directors’ Office on 1 August 2018. Sara has extensive experience with policy development, EU regulation and implementation into Danish law and with EU and international collaboration. Sara has previously worked in the Ministry of Immigration and Integration, the Ministry of Education and the Ministry of Environment and Food of Denmark. |
Iben Vitved
|
Contactibvi@dkma.dk EducationMSc in Economics ResponsibilitiesFinances, finance act, budgets and fee calculations, including contact with the department and the Danish national audit office. Cross-cutting processes and IT support. Short descriptionFor a number of years, Iben has been working with public financial management and business development. Most recently, Iben worked as chief financial officer of the Danish Security and Intelligence Service (PET) and at the IT University of Copenhagen. Iben gained her experience in the health sector when she was chief accountant of the Danish Health Authority from 2005 to 2010. |
Mette Aaboe Hansen
|
Contactmah@dkma.dk EducationMaster of Laws ResponsibilitiesClinical trials, authorisation of human and veterinary medicinal products, compassionate use permits, product information, medicine prices and medicines law. Definition of medicinal products and illegal trading of medicinal products. Short descriptionMette Aaboe Hansen has worked as director of division at the Danish Medicines Agency since 2006 with special focus on authorisation of medicinal products, compassionate use permits and medicines law, including the related EU law, and since 2013 she has also been working with clinical trials and illegal trading of medicinal products. Before joining the pharmaceutical area, Mette worked at the Danish Veterinary and Food Administration and has experience with EU legislation, negotiation and implementation into Danish law. Over the years, Mette has also worked with issues related to medicines data, both in relation to the register of medicinal products and the exchange of data, nationally and within the EU. |
Merete Hermann
|
Contactmhe@dkma.dk EducationMSc in Pharmacy ResponsibilitiesInspection of companies, pharmacies, clinical trials etc. Company authorisations and import and export certificates for medicinal products and euphoriant substances. Complaints and reports of quality defects in medicinal products, including withdrawals of medicinal products. Control laboratory and standardisation work under the European Pharmacopoeia as well as publication of Danish Drug Standards. Both the inspectorate and the control laboratory hold an EN/ISO accreditation. Short descriptionMerete Hermann has been director of division at the Danish Medicines Agency since 2014 and before that she was head of unit since 2008. Merete's focus is on the quality of medicinal products through the control of medicinal products and authorisation and control of companies. Merete is an experienced manager and has worked in the private sector throughout most of her career. |
Kim Helleberg Madsen
|
Contactkhm@dkma.dk EducationMSc in Political Science ResponsibilitiesPharmacies, reimbursement for medicines and nutritional products as well as healthcare professionals working with industry. Short descriptionKim Helleberg Madsen has worked at the Danish Medicines Agency since 2004. He previously worked for the Danish EU representation in Brussels as a health attaché and for the European Commission with e.g. risk assessment, food legislation and biotechnology as well as for the international office of the Danish Ministry of Health. |
Nikolai Brun
|
Contactncbr@dkma.dk EducationMD from the University of Copenhagen 1994. Ph.D. from the University of Copenhagen with technical studies at University of Pennsylvania 1998. Various management and leadership courses. ResponsibilitiesMedical and statistical evaluation of new medicinal products. Medical and statistical evaluation in general with input to other divisions. Scientific advice procedures. Short descriptionNikolai Brun started as Director of Division of the newly formed Medical Evaluation & Biostatistics on 1 March 2017. Having trained in general medicine and pediatrics, Nikolai Brun joined the industry in 2000 and has extensive experience in drug development and medical affairs from both the pharmaceutical industry and biotech employments. He has held senior positions as head of medical teams and matrix organisations at Novo Nordisk, Genzyme and Genmab. |
Jens Piero Quartarolo
|
Contactjepq@dkma.dk EducationMD from the University of Copenhagen 1995, Master of Business Administration (2005) and Master of Science (2011) from Henley Business School, University of Reading, UK. ResponsibilitiesPharmacovigilance, including management and analysis of adverse reaction reports, signal generation and risk minimisation. In addition, Jens Piero Quartarolo is responsible for medical devices, including the authorisation of clinical trials involving medical devices and market surveillance. Short descriptionJens Piero Quartarolo has clinical experience from general practice as well as the areas of gynaecology and obstetrics. During the past 20 years, Jens has worked in both the Danish and the international pharmaceutical industry. His responsibilities have included medical management of areas such as clinical research, monitoring of adverse reactions, registration of medicinal products and medical information. Most recently, Jens Piero Quartarolo formed part of the European management team of the US-based company CELGENE. Previously, Jens Piero Quartarolo held executive positions in MSD, Ferring Pharmaceuticals, Organon/Schering-Plough and Abbvie. |
